{
  "columnHierarchy": {
    "epochs": [
      {
        "id": "epoch_1",
        "name": "Screening",
        "instanceType": "StudyEpoch",
        "type": {
          "id": "1e2aa29b-0832-445e-a7ce-f9542d13a4bb",
          "code": "C98779",
          "codeSystem": "http://www.cdisc.org",
          "codeSystemVersion": "2024-09-27",
          "decode": "Screening Epoch",
          "instanceType": "Code"
        }
      },
      {
        "id": "epoch_2",
        "name": "Treatment Phase (Q3W)",
        "instanceType": "StudyEpoch",
        "type": {
          "id": "fde5061b-f11d-4f0c-a380-44a1c39a9d86",
          "code": "C98780",
          "codeSystem": "http://www.cdisc.org",
          "codeSystemVersion": "2024-09-27",
          "decode": "Treatment Epoch",
          "instanceType": "Code"
        }
      },
      {
        "id": "epoch_3",
        "name": "Treatment Discontinuation",
        "instanceType": "StudyEpoch",
        "type": {
          "id": "0ed3001f-2579-473d-885d-18d238492269",
          "code": "C98780",
          "codeSystem": "http://www.cdisc.org",
          "codeSystemVersion": "2024-09-27",
          "decode": "Treatment Epoch",
          "instanceType": "Code"
        }
      },
      {
        "id": "epoch_4",
        "name": "Survival Follow-Up",
        "instanceType": "StudyEpoch",
        "type": {
          "id": "36d10d48-d665-41dc-9a2e-ab72eec607da",
          "code": "C98781",
          "codeSystem": "http://www.cdisc.org",
          "codeSystemVersion": "2024-09-27",
          "decode": "Follow-up Epoch",
          "instanceType": "Code"
        }
      }
    ],
    "encounters": [
      {
        "id": "enc_1",
        "name": "Screening (-28 to -1)",
        "instanceType": "Encounter",
        "type": {
          "id": "4d293b87-0567-41e2-9d4f-18002a2962b0",
          "code": "C48262",
          "codeSystem": "http://www.cdisc.org",
          "codeSystemVersion": "2024-09-27",
          "decode": "Screening",
          "instanceType": "Code"
        },
        "epochId": "epoch_1"
      },
      {
        "id": "enc_2",
        "name": "Screening (-7 to -1)",
        "instanceType": "Encounter",
        "type": {
          "id": "1e75c538-4800-45f0-8638-697c7c4f4181",
          "code": "C48262",
          "codeSystem": "http://www.cdisc.org",
          "codeSystemVersion": "2024-09-27",
          "decode": "Screening",
          "instanceType": "Code"
        },
        "epochId": "epoch_1"
      },
      {
        "id": "enc_3",
        "name": "Day 1 of Each Cycle",
        "instanceType": "Encounter",
        "type": {
          "id": "498d5901-17d4-48cc-b903-f5eb1bb202f2",
          "code": "C82517",
          "codeSystem": "http://www.cdisc.org",
          "codeSystemVersion": "2024-09-27",
          "decode": "Baseline",
          "instanceType": "Code"
        },
        "epochId": "epoch_2"
      },
      {
        "id": "enc_4",
        "name": "≤ 30 Days after Last Dose",
        "instanceType": "Encounter",
        "type": {
          "id": "7da6ff67-bb63-4b77-b5d2-eebec6a50d94",
          "code": "C99156",
          "codeSystem": "http://www.cdisc.org",
          "codeSystemVersion": "2024-09-27",
          "decode": "Scheduled Visit",
          "instanceType": "Code"
        },
        "epochId": "epoch_3"
      },
      {
        "id": "enc_5",
        "name": "Survival Follow-Up",
        "instanceType": "Encounter",
        "type": {
          "id": "27dbb43a-2752-43d5-99b8-022838740cf9",
          "code": "C99158",
          "codeSystem": "http://www.cdisc.org",
          "codeSystemVersion": "2024-09-27",
          "decode": "Follow-up",
          "instanceType": "Code"
        },
        "epochId": "epoch_4"
      }
    ],
    "plannedTimepoints": [
      {
        "id": "pt_1",
        "visit": "-28 to -1",
        "epoch": "",
        "epochId": "",
        "day": "",
        "window": null,
        "encounterId": "enc_1",
        "instanceType": "Timing"
      },
      {
        "id": "pt_2",
        "visit": "-7 to -1",
        "epoch": "",
        "epochId": "",
        "day": "",
        "window": null,
        "encounterId": "enc_2",
        "instanceType": "Timing"
      },
      {
        "id": "pt_3",
        "visit": "Day 1",
        "epoch": "",
        "epochId": "",
        "day": "",
        "window": null,
        "encounterId": "enc_3",
        "instanceType": "Timing"
      },
      {
        "id": "pt_4",
        "visit": "≤ 30 Days",
        "epoch": "",
        "epochId": "",
        "day": "",
        "window": null,
        "encounterId": "enc_4",
        "instanceType": "Timing"
      },
      {
        "id": "pt_5",
        "visit": "Survival",
        "epoch": "",
        "epochId": "",
        "day": "",
        "window": null,
        "encounterId": "enc_5",
        "instanceType": "Timing"
      }
    ]
  },
  "rowGroups": [
    {
      "id": "grp_1",
      "name": "General Assessments",
      "description": null,
      "childIds": [],
      "instanceType": "Activity",
      "activityNames": [
        "Signed Informed Consent Form(s)",
        "Review of eligibility criteria",
        "Medical, surgical, and cancer histories, including demographic information",
        "Complete physical examination",
        "Limited physical examination",
        "ECOG Performance Status",
        "Patient-reported outcomes",
        "Tumor assessment",
        "Vital signs",
        "Weight",
        "Height",
        "12-lead ECG",
        "EGD"
      ]
    },
    {
      "id": "grp_2",
      "name": "Laboratory Assessments",
      "description": null,
      "childIds": [],
      "instanceType": "Activity",
      "activityNames": [
        "Hematology",
        "Serum chemistry",
        "HIV, HBV, HCV serology",
        "Quantitative HBsAg, HBV DNA, HCV RNA",
        "α-fetoprotein",
        "Coagulation panel (aPTT, INR)",
        "Urinalysis",
        "TSH, free T3, free T4",
        "Pregnancy test"
      ]
    },
    {
      "id": "grp_3",
      "name": "Specialized Samples & Treatment",
      "description": null,
      "childIds": [],
      "instanceType": "Activity",
      "activityNames": [
        "Serum PK sample",
        "Serum ADA sample",
        "Pharmacodynamic samples for biomarkers",
        "Plasma sample for RBR (optional)",
        "Archival tumor tissue sample",
        "Concomitant medications",
        "Adverse events",
        "Study treatment infusion",
        "Sorafenib dispensing",
        "Survival and anti-cancer therapy follow-up"
      ]
    }
  ],
  "footnotes": [
    "a. The first dosing date (Cycle 1, Day 1) should occur within 3 business days from randomization.",
    "b. Written informed consent can be obtained up to 30 days prior to study entry.",
    "c. Patients will be asked to return to the clinic 30 days after the last dose of study treatment.",
    "g. ECOG Performance Status, limited physical examination, local laboratory assessments, and PROs may be obtained ≤ 96 hours before Day 1 of each cycle.",
    "i. Tumor assessments will be performed at baseline, every 6 weeks (± 1 week) for the first 54 weeks.",
    "z. Local laboratory assessments from each cycle must be reviewed prior to study treatment administration."
  ]
}